John Nuss insider trades: Ventyx Biosciences (VTYX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | VTYX | ↓ Sell | 12,675 | $7.72 | $98K | Direct | Dec 19, 2025 (1d) |
| Apr 2, 2025 | VTYX | ↓ Sell | 1,887 | $1.07 | $2K | Direct | Apr 3, 2025 (1d) |
| Dec 27, 2024 | VTYX | ↓ Sell | 21,119 | $2.36 | $50K | Direct | Dec 30, 2024 (3d) |
| Dec 19, 2024 | VTYX | ↓ Sell | 13,161 | $2.26 | $30K | Direct | Dec 19, 2024 (0d) |
| Apr 2, 2024 | VTYX | ↓ Sell | 1,651 | $5.40 | $9K | Direct | Apr 3, 2024 (1d) |
| Dec 20, 2023 | VTYX | ↓ Sell | 17,628 | $2.12 | $37K | Direct | Dec 21, 2023 (1d) |
| Oct 3, 2023 | VTYX | ↓ Sell | 10,000 | $29.99 | $300K | Direct | Oct 4, 2023 (1d) |
| Sep 5, 2023 | VTYX | ↓ Sell | 10,000 | $32.60 | $326K | Direct | Sep 7, 2023 (2d) |
| Aug 3, 2023 | VTYX | ↓ Sell | 10,000 | $35.60 | $356K | Direct | Aug 4, 2023 (1d) |
| Jul 3, 2023 | VTYX | ↓ Sell | 20,000 | $39.58 | $792K | Direct | Jul 5, 2023 (2d) |
| Jun 5, 2023 | VTYX | ↓ Sell | 10,000 | $34.35 | $343K | Direct | Jun 7, 2023 (2d) |
| May 3, 2023 | VTYX | ↓ Sell | 10,000 | $38.64 | $386K | Direct | May 4, 2023 (1d) |
| Apr 3, 2023 | VTYX | ↓ Sell | 30,000 | $32.87 | $986K | Direct | Apr 5, 2023 (2d) |
| Dec 22, 2022 | VTYX | ↓ Sell | 13,812 | $31.61 | $437K | Direct | Dec 23, 2022 (1d) |
| Dec 13, 2022 | VTYX | ↓ Sell | 35,000 | $34.32 | $1.2M | Direct | Dec 15, 2022 (2d) |
| Dec 5, 2022 | VTYX | ↓ Sell | 50,000 | $28.23 | $1.4M | Direct | Dec 6, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other VTYX insiders
Open-market trades in the last 12 months
About John Nuss's insider trades
John Nuss is Chief Scientific Officer at Ventyx Biosciences (VTYX). Since Dec 5, 2022, John has reported no open-market purchases and 16 sales worth $6.8M on SEC Form 4. In the last 12 months: 1 sale ($98K).
Their filings also include option exercises (14 filings), grants and awards (6 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VTYX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.